36 related articles for article (PubMed ID: 27105972)
1. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis.
Siedhoff MT; Wheeler SB; Rutstein SE; Geller EJ; Doll KM; Wu JM; Clarke-Pearson DL
Am J Obstet Gynecol; 2015 May; 212(5):591.e1-8. PubMed ID: 25817518
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcomes of unexpected uterine leiomyosarcoma: A single-center retrospective analysis of 5528 consecutive hysterectomies.
Casarin J; Ghezzi F; Lembo A; Artuso V; Schivardi G; Galati EF; Ambrosoli AL; Bogani G; Multinu F; Cromi A
J Surg Oncol; 2024 Mar; 129(3):517-522. PubMed ID: 37974522
[TBL] [Abstract][Full Text] [Related]
4. Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.
Hosh M; Antar S; Nazzal A; Warda M; Gibreel A; Refky B
Int J Gynecol Cancer; 2016 Jul; 26(6):1098-104. PubMed ID: 27177280
[TBL] [Abstract][Full Text] [Related]
5. Sarcoma of the Uterus. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/074, April 2021).
Denschlag D; Ackermann S; Battista MJ; Cremer W; Egerer G; Fehr M; Follmann M; Haase H; Harter P; Hettmer S; Horn LC; Juhasz-Boess I; Kast K; Köhler G; Kröncke T; Lindel K; Mallmann P; Meyer-Steinacker R; Mustea A; Petru E; Reichardt P; Schmidt D; Strauss HG; Thiel F; Ulrich UA; Vogl T; Vordermark D; Wallwiener M; Gass P; Beckmann MW
Geburtshilfe Frauenheilkd; 2022 Dec; 82(12):1337-1367. PubMed ID: 36467974
[No Abstract] [Full Text] [Related]
6. Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
Kasper B; Achee A; Schuster K; Wilson R; van Oortmerssen G; Gladdy RA; Hemming ML; Huang P; Ingham M; Jones RL; Pollack SM; Reinke D; Sanfilippo R; Schuetze SM; Somaiah N; Van Tine BA; Wilky B; Okuno S; Trent J
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672607
[TBL] [Abstract][Full Text] [Related]
7. Sarcoma of the Uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019).
Denschlag D; Ackermann S; Battista MJ; Cremer W; Egerer G; Follmann M; Haas H; Harter P; Hettmer S; Horn LC; Juhasz-Boess I; Kast K; Köhler G; Kröncke T; Lindel K; Mallmann P; Meyer-Steinacker R; Mustea A; Petru E; Reichardt P; Schmidt D; Strauss HG; Tempfer C; Thiel F; Ulrich U; Vogl T; Vordermark D; Gass P; Beckmann MW
Geburtshilfe Frauenheilkd; 2019 Oct; 79(10):1043-1060. PubMed ID: 31656317
[No Abstract] [Full Text] [Related]
8. Is Laparoscopic Power Morcellation of Fibroids a Cardinal Sin in 2017?
Allahbadia GN
J Obstet Gynaecol India; 2017 Feb; 67(1):1-6. PubMed ID: 28242959
[TBL] [Abstract][Full Text] [Related]
9. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis.
Bogani G; Cliby WA; Aletti GD
Gynecol Oncol; 2015 Apr; 137(1):167-72. PubMed ID: 25462199
[TBL] [Abstract][Full Text] [Related]
10. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
Parker WH; Pritts EA; Olive DL
Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
[TBL] [Abstract][Full Text] [Related]
11. Effects of morcellation on long-term outcomes in patients with uterine leiomyosarcoma.
Nemec W; Inwald EC; Buchholz S; Klinkhammer Schalke M; Gerken M; Ortmann O
Arch Gynecol Obstet; 2016 Oct; 294(4):825-31. PubMed ID: 27105972
[TBL] [Abstract][Full Text] [Related]
12. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
[TBL] [Abstract][Full Text] [Related]
14. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
[TBL] [Abstract][Full Text] [Related]
15. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
Raine-Bennett T; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE
Obstet Gynecol; 2016 Jan; 127(1):29-39. PubMed ID: 26646120
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
